Metabolic effects of 1-methyl-4-phenylpyridinium (MPP+) in primary neuron cultures

Journal of Neuroscience Research

Volumn 62, Issue 6, 2000, Pages 814-820

  Marini, Ann M ^a   Nowak Jr , Thaddeus S ^b  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

ATP; Cerebellar granule cells; Energy metabolism; MPP+; Neurotoxicity; Phosphocreatine

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; LACTIC ACID;

ANIMAL CELL; ARTICLE; CELL PH; CELL VIABILITY; CONTROLLED STUDY; ENERGY METABOLISM; GLYCOLYSIS; GRANULAR CELL; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ADENOSINE TRIPHOSPHATE; ANIMALS; CELLS, CULTURED; CEREBELLUM; GLUCOSE; HERBICIDES; LACTIC ACID; NEURONS; PHOSPHOCREATINE; RATS;

EID: 0034672314     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-4547(20001215)62:6<814::AID-JNR8>3.0.CO;2-F     Document Type: Article

References (59)

1. Oxidative effects of MPTP in the midbrain
2. 1-Methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells is enhanced by preventing glycolysis
3. A primate model of Parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
4. Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain
5. Metabolism of the neurotoxic tertiary amine MPTP by brain monoamine oxidase
6. +-induced cell death in a dopaminergic neuronal cell line: Role of macromolecule synthesis, cytosolic calcium, caspase, and bcl-2-related proteins
7. Oxy-radical toxicity in catecholamine neurons
8. Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys
9. Stability of brain intracellular lactate and (31)p-metabolite levels at reduced intracellular pH during prolonged hypercapnia in rats
10. Cerebral energy metabolism during electroshocks seizures in mice
11. Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro
12. A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
13. +) cause rapid ATP depletion in isolated hepatocytes
14. Fructose prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced ATP depletion and toxicity in isolated hepatocytes
15. Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons
16. Compartmentation of brain-type creatine kinase and ubiquitous mitochondrial creatine kinase in neurons: Evidence for a creatine phosphate energy shuttle in adult rat brain
17. The role of depolarizanon in the survival and differentiation of cerebellar granule cells in culture
18. Glutamate receptor subtypes in cultured cerebellar neurons: Modulation of glutamate and gamma-aminobutyric acid release
19. Studies on the characterization of the inhibitory mechanism of 4'alkylated 1-methyl-4-phenylpyridinium and phenylpyridine analogues in mitochondria and electron transport particles
20. Neurotoxicity of the meperidine analogue MPTP in brain catecholamine neurons in the mouse
21. Effects of MPTP on neostriatal dopamine in mice
22. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine by monoamine oxidase inhibitors
23. +-induced toxicity: Comparison between MN9D and CHO cells
24. +)-related compounds in rat pheochromocytoma PC12 cells
25. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine
26. + (1-methyl-4-phenylpyridinium) with mitochondrial respiration vs. oxidative stress
27. MPTP-induced ATP depletion and cell death in neuroblastoma X glioma hybrid NG 108-115 cells: Protection by glucose and sensitization by tetraphenylborate
28. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP) in the squirrel monkey
29. Pargyline prevents MPTP-induced Parkinsonism in primates
30. Autoradiographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cell cultures
31. Protein measurement with the Folin phenol reagent
32. Effect of ischemia on known substrates and cofactors of the glycolytic pathway in brain
33. The enzymatic measurement of adenine nucleotides and P-creatine in picomole amounts
34. The neurotoxicity of 1-methyl-4-phenylpyridinium in cultured cerebellar granule cells
35. Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate
36. N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis
37. Intraneuronal generation of a pyridinium metabolite may cause drug-induced Parkinsonism
38. Creatine and cyclocreatine attenuate MPTP neurotoxicity
39. A simple analysis of the 'phosphocreatine shuttle.'
40. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
41. Changes in brain energy metabolism and protein synthesis following transient bilateral ischemia in the gerbil
42. FGF-2 modulates dopamine and dopamine-related striatal transmitter systems in the intact and MPTP-lesioned mouse
43. +, the neurotoxic bioactivation product of 1-methyl-1,2,3,6-tetrahydropyridine is near the Q-binding site of NADH Dehydrogenase
44. Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxsc metabolite of 1-methyl-4-phenyl 1,2,3,6-tetrahydropyfidine, by mitochondria
45. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A neurochemical and morphological reassessment
46. The state of magnesium in cells as estimated from the adenylate kinase equilibrium
47. +-evoked hydroxyl radical formation but not dopamine efflux in rat striatum
48. Creatine kinase equilibrium and lactate content compared with muscle pH in tissue samples obtained after isometric exercise
49. Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: Cytochemical and morphological evidence
50. GM1 ganglioside treatment promotes recovery of striatal dopamine concentrations in the mouse model of MPTP-induced parkinsonism
51. The effect of hypercapnia upon intracellular pH in the brain, evaluated by the bicarbonate-carbonic acid method and from the creatine phosphokinase equilibrium
52. MPTP and MPTP analogs-induced cell death in cultured rat hepatocytes involving the formation of pyridinium metabolites
53. 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism
54. Cytosolic phosphorylation potential
55. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium
56. Creatine: Biosynthesis, regulation and function
57. Respiratory chain inhibition induces tolerance to focal cerebral ischemia
58. +, and not bound metabolites, as the operative neurotoxin